$SNPS

HSBC Upgrades Synopsys, Sets Street-High $700 Target

HSBC upgraded Synopsys to Buy and set a $700 price target, citing a shift to royalties and AI-driven demand. The target is 60% above current levels and highest on Wall Street. Synopsys reported strong Q3 earnings and raised its full-year outlook.

Original reporting
Published Sep 25, 2026, 6:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 25, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
HSBC Upgrades Synopsys, Sets Street-High $700 Target — source image
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The upgrade could attract momentum traders and long‑term investors seeking exposure to AI‑enabled chip design tools.

02

Market read

Analyst upgrade with a high target is a catalyst for short‑term price action and may influence sector sentiment.

03

What to watch

Potential slowdown in AI spending or competitive pressure from rivals could temper upside.

Relevance 7/10Novelty 7/10Timing: intraday today

Background

HSBC raised its FY2027 EPS estimate and valuation multiple, citing royalty growth and AI‑driven demand.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

HSBC upgraded Synopsys to Buy and raised the price target to $700, prompting a 1.81% intraday rise.

Expected impact

Potential further upside if investors follow the new target.

Evidence & confidence

The upgrade is fresh, the target implies >60% upside, and the stock already moved up on the news.

Market effects

Boosts sentiment for the EDA (electronic design automation) sector as AI demand is highlighted.

Positive for US tech stocks, especially those with AI exposure.

Limited to semiconductor and AI‑related equities worldwide.

Counterpoint

The upgrade may be premature if royalty model execution lags, keeping valuation high.

Key entities

  • HSBC

    Equity research firm issuing the upgrade and target.

  • Synopsys

    Chip design software provider receiving the upgrade.

Related articles

$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

$SNPSMed

Why Synopsys Stock Popped, Then Dropped

Synopsys (SNPS) stock rose 5% then dropped 4% after Q3 earnings beat expectations, with 42.5% sales growth and 89% GAAP earnings increase. CEO Sassine Ghazi cited AI chip complexity driving demand. Analysts upgraded SNPS, with HSBC setting a $700 target based on non-GAAP earnings.

$SNPSHigh

HSBC Upgrades Synopsys to Buy, Sees 28% Earnings Growth Through 2028

HSBC upgraded Synopsys (SNPS) to Buy with a $700 price target, citing a potential shift in business model that could boost earnings growth to 28% through 2028. Synopsys reported 42% revenue growth and a $10.9B backlog last quarter, and has a new AI partnership with TSMC. Seventeen analysts raised EPS estimates in the past 30 days, with HSBC's target 28% above the Street consensus.